Breaking News Instant updates and real-time market news.

INVA

Innoviva

$14.43

-0.16 (-1.10%)

, MYL

Mylan

$41.65

-0.2 (-0.48%)

08:28
06/14/18
06/14
08:28
06/14/18
08:28

Morgan Stanley says Mylan Advair news likely seen as positive for Innoviva

After Mylan (MYL) announced the FDA has identified minor deficiencies that will delay the launch of its generic Advair product, Morgan Stanley analyst Matthew Harrison said he expects the market to view this as a positive for Innoviva (INVA), which he predicts will be up 5% or more on the news. Harrison, who continues to anticipate a generic Advair entry in 2018, keeps an Underweight rating on Innoviva shares.

INVA

Innoviva

$14.43

-0.16 (-1.10%)

MYL

Mylan

$41.65

-0.2 (-0.48%)

  • 13

    Nov

INVA Innoviva
$14.43

-0.16 (-1.10%)

11/20/17
DBAB
11/20/17
INITIATION
Target $13
DBAB
Hold
Innoviva initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Esther Rajavelu started Innoviva (INVA) with a Hold rating and $13 price target. The analyst is concerned about revenue concentration and sees no near-term growth opportunities outside of the GlaxoSmithKline (GSK) partnership.
11/20/17
11/20/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Innoviva (INVA) initiated with a Hold at Deutsche Bank. 2. National Vision (EYE) was initiated with an Overweight at Morgan Stanley, an Outperform at Wells Fargo, a Buy at Jefferies and Citi, as well as a Neutral at Goldman Sachs, UBS, and BofA/Merrill. 3. Ablynx (ABLX) was initiated with an Overweight at JPMorgan, an Outperform at Baird, and a Buy at Ladenburg. 4. Blue Apron (APRN) initiated with a Sector Weight at KeyBanc. 5. BP Midstream (BPMP) was initiated with an Overweight at JPMorgan, a Buy at UBS and Citi, an Equal Weight at Morgan Stanley and Barclays, as well as a Neutral at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/18/17
MSCO
12/18/17
NO CHANGE
MSCO
Morgan Stanley sees opportunities in biotech amid 'limited' investor conviction
With clinical catalysts in large-cap Biotechnology limited to only five key Phase III readouts - three of which are from Alexion (ALXN) - investors are describing their 2018 picks in the space as the "least worst" of the group, according to Morgan Stanley analyst Matthew Harrison. However, he believes this lack of conviction creates real opportunity for outsized moves in 2018, with Amgen (AMGN) identified by Harrison as the biggest potential beneficiary of M&A given "its likely newfound access" to about $39B in offshore cash. Other biotech names the analyst highlights on the up side include Biogen (BIIB), BioMarin (BMRN), Biohaven (BHVN) and Sarepta (SRPT). Meanwhile, Harrison highlights his concerns about potential downside for BioVerativ (BIVV) and Innoviva (INVA), on both of which he keeps Underweight ratings.
04/19/18
BREN
04/19/18
INITIATION
Target $22
BREN
Buy
Innoviva initiated with a Buy at Berenberg
Berenberg analyst Patrick Trucchio initiated Innoviva with a Buy and $22 price target.
MYL Mylan
$41.65

-0.2 (-0.48%)

06/14/18
MZHO
06/14/18
NO CHANGE
Target $51
MZHO
Buy
Mylan to recover from 'modest' generic Advair delay, says Mizuho
Mizuho analyst Irina Koffler says Mylan's "modest" delay for generic Advair approval is unsurprising and unlikely to impact the company's 2018 guidance. She expects the stock to recover and reiterates a Buy rating on the name with a $51 price target.
06/14/18
RBCM
06/14/18
NO CHANGE
Target $42
RBCM
Sector Perform
Mylan's stock may pull back through Q2, says RBC Capital
RBC Capital analyst Randall Stanicky kept his $42 price target and Sector Perform rating on Mylan following yesterday's FDA delay of generic Advair due to "minor deficiencies". The analyst notes that the company may be faced with worse than expressed business pressure and is also concerned that the Street may have over-modeled the Advair contribution, warning that the stock price may pull back through Q2. Stanicky says investors should await a better entry point opportunity on Mylan.
06/14/18
MSCO
06/14/18
NO CHANGE
Target $50
MSCO
Overweight
Morgan Stanley says generic Advair delay a small negative for Mylan
Morgan Stanley analyst David Risinger called Mylan's announcement that generic Advair will not be approved by its June 27 action date a "small negative, but not a major surprise." He sees potential for approval this fall, while noting that the company previously warned with its Q1 earnings release that there was risk that it could need to lower its 2018 guidance range. He keeps an Overweight rating on Mylan shares, citing the stock's low valuation and the company's pipeline opportunities.
06/14/18
WELS
06/14/18
NO CHANGE
WELS
Market Perform
Advair generic delay negative news for Mylan, says Wells Fargo
Wells Fargo analyst David Maris notes that Mylan announced that it received an update from the FDA concerning its generic Advair application and the FDA has identified minor deficiencies that will be relayed in a Complete Response Letter on June 27. While noting that he does not know how long it will take Mylan to respond to the CRL, the analyst says the delay is negative news for the company, but less so from a financial basis than a sentiment basis. Further, Maris believes this delay is important as this is a high-profile product that may already be in market expectations, and the delay may take away some excitement about a near-term catalyst. The fact Mylan said it will determine after getting the CRL whether this has any impact to its 2018 outlook, also creates some uncertainty, he contends. Maris reiterates a Market Perform rating on the shares.

TODAY'S FREE FLY STORIES

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

19:30
09/23/18
09/23
19:30
09/23/18
19:30
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

SKYAY

Sky

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

RBC

Regal Beloit

$85.80

-0.25 (-0.29%)

TLRY

Tilray

$123.16

-53.365 (-30.23%)

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

CAT

Caterpillar

$156.39

0.38 (0.24%)

AMAT

Applied Materials

$39.62

0.22 (0.56%)

BWA

BorgWarner

$45.24

-0.53 (-1.16%)

KEY

KeyCorp

$20.78

0.02 (0.10%)

PH

Parker-Hannifin

$190.52

0.01 (0.01%)

AAPL

Apple

$217.65

-2.35 (-1.07%)

CSCO

Cisco

$48.51

0.77 (1.61%)

INTC

Intel

$46.64

-0.56 (-1.19%)

IBM

IBM

$151.29

0.12 (0.08%)

MSFT

Microsoft

$114.70

1.13 (0.99%)

ORCL

Oracle

$51.08

0.65 (1.29%)

BRK.A

Berkshire Hathaway

$331,710.00

-1090 (-0.33%)

BRK.B

Berkshire Hathaway

$220.57

-1.24 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 29

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 09

    Oct

  • 10

    Oct

  • 18

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 28

    Nov

  • 03

    Mar

RBC

Regal Beloit

$85.80

-0.25 (-0.29%)

19:08
09/23/18
09/23
19:08
09/23/18
19:08
Earnings
Regal Beloit confirms 2018 adjusted diluted EPS guidance of $5.70-$6.00 »

Regal sees 2018 GAAP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

RBC

Regal Beloit

$85.80

-0.25 (-0.29%)

19:04
09/23/18
09/23
19:04
09/23/18
19:04
Hot Stocks
Regal Beloit announces planned CEO retirement »

Regal Beloit announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

TRXC

TransEnterix

$6.43

-0.035 (-0.54%)

18:14
09/23/18
09/23
18:14
09/23/18
18:14
Hot Stocks
TransEnterix acquires assets, intellectual property from MST Medical Surgery »

TransEnterix announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 27

    Nov

T

AT&T

$33.88

0.44 (1.32%)

, CMCSA

Comcast

$37.91

0.1 (0.26%)

17:24
09/23/18
09/23
17:24
09/23/18
17:24
Hot Stocks
Box Office Battle: 'The House With a Clock in Its Walls' opens to $26.9M in U.S. »

Comcast (CMCSA)…

T

AT&T

$33.88

0.44 (1.32%)

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$57.04

-2.065 (-3.49%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

LGF.A

Lionsgate

$22.38

-0.09 (-0.40%)

DIS

Disney

$110.72

-0.9 (-0.81%)

VIAB

Viacom

$32.36

0.52 (1.63%)

VIA

Viacom

$34.50

-0.5 (-1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 26

    Sep

  • 21

    Oct

  • 06

    Nov

  • 12

    Nov

DVMT

Dell Technologies

$96.27

0.27 (0.28%)

17:04
09/23/18
09/23
17:04
09/23/18
17:04
Periodicals
Dell to interview banks for IPO instead of acquisition, WSJ reports »

Dell Technologies is said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPP

WPP

$75.11

-0.06 (-0.08%)

16:23
09/23/18
09/23
16:23
09/23/18
16:23
Periodicals
WPP preparing to merge Young & Rubicam, digital ad firm VML, WSJ reports »

WPP new CEO Mark Read is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$69.05

0.25 (0.36%)

16:15
09/23/18
09/23
16:15
09/23/18
16:15
Hot Stocks
Abbott announces positive clinical study results from MitraClip trial »

Abbott announced positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

AZN

AstraZeneca

$37.69

-0.025 (-0.07%)

12:59
09/23/18
09/23
12:59
09/23/18
12:59
Periodicals
AstraZeneca CEO warns of medicine shortages following Brexit, Reuters reports »

Britain could see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

12:54
09/23/18
09/23
12:54
09/23/18
12:54
Periodicals
Volkswagen's Porsche dropping diesel in EV push, Reuters says »

Volkswagen's Porsche…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

12:49
09/23/18
09/23
12:49
09/23/18
12:49
Periodicals
Apple planning for delays to Battersea HQ, Bloomberg reports »

Apple is making…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

PYPL

PayPal

$90.76

0.17 (0.19%)

12:43
09/23/18
09/23
12:43
09/23/18
12:43
Periodicals
PayPal replaces executive in charge of Venmo, WSJ reports »

PayPal is replacing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

MDT

Medtronic

$97.85

0.38 (0.39%)

12:37
09/23/18
09/23
12:37
09/23/18
12:37
Hot Stocks
Medtronic presents IN.PACT global study three-year data »

Medtronic announced data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

12:29
09/23/18
09/23
12:29
09/23/18
12:29
Hot Stocks
Comcast prevails with highest offer price in auction for Sky »

Comcast (CMCSA) published…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$97.85

0.38 (0.39%)

12:26
09/23/18
09/23
12:26
09/23/18
12:26
Hot Stocks
Clinical study shows safety, efficacy outcomes for Medtronic Resolute Onyx DES »

Investigators unveiled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

12:20
09/23/18
09/23
12:20
09/23/18
12:20
Hot Stocks
Boston Scientific announced positive 12-month data from IMPERIAL trial »

Boston Scientific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

12:16
09/23/18
09/23
12:16
09/23/18
12:16
Hot Stocks
Nightstar reports proof of concept data from dose escalation in XIRIUS trial »

Nightstar Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

, AGN

Allergan

$191.34

-1.11 (-0.58%)

04:55
09/23/18
09/23
04:55
09/23/18
04:55
Conference/Events
European Society of Retina Specialists to hold a conference »

18th Congress of EURETINA…

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

AGN

Allergan

$191.34

-1.11 (-0.58%)

ALIM

Alimera Sciences

$1.07

(0.00%)

BABY

Natus Medical

$34.45

-0.2 (-0.58%)

BHC

Bausch Health

$24.92

-0.07 (-0.28%)

BAYRY

Bayer

$0.00

(0.00%)

ELXMF

Ellex Medical Lasers

$0.00

(0.00%)

GKOS

Glaukos

$58.78

-1.69 (-2.79%)

IRIX

IRIDEX

$6.52

0.08 (1.24%)

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

NVS

Novartis

$85.46

-0.505 (-0.59%)

OCUL

Ocular Therapeutix

$6.45

0.03 (0.47%)

RHHBY

Roche

$0.00

(0.00%)

SHPG

Shire

$178.32

-1.68 (-0.93%)

STAA

STAAR Surgical

$47.00

-0.9 (-1.88%)

TMDI

Titan Medical

$2.24

0.02 (0.90%)

TTNP

Titan Pharmaceuticals

$0.22

-0.2833 (-56.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 09

    Oct

  • 16

    Oct

  • 22

    Oct

  • 28

    Oct

  • 29

    Oct

  • 15

    Nov

  • 27

    Nov

  • 21

    Dec

  • 28

    Dec

  • 15

    Feb

  • 25

    Feb

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

14:32
09/22/18
09/22
14:32
09/22/18
14:32
Periodicals
Comcast outbids Fox in battle for Sky, Reuters reports »

Comcast (CMCSA; CMCSK)…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

, COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

13:36
09/22/18
09/22
13:36
09/22/18
13:36
Conference/Events
CoBiz Financial to host special shareholder meeting »

Special Shareholder…

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

AMRH

AMERI Holdings

$1.44

-0.04 (-2.70%)

13:30
09/22/18
09/22
13:30
09/22/18
13:30
Conference/Events
AMERI Holdings to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BRK.A

Berkshire Hathaway

$331,710.00

-1090 (-0.33%)

13:26
09/22/18
09/22
13:26
09/22/18
13:26
Periodicals
Berkshire Hathaway still looks underpriced, Barron's says »

Class A shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLGO

BioLargo

$0.00

(0.00%)

13:11
09/22/18
09/22
13:11
09/22/18
13:11
Conference/Events
BioLargo to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZWI

Citizens Community Bancorp

$14.13

0.03 (0.21%)

12:56
09/22/18
09/22
12:56
09/22/18
12:56
Conference/Events
Citizens Community Bancorp to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SF

Stifel Financial

$54.86

-0.78 (-1.40%)

12:50
09/22/18
09/22
12:50
09/22/18
12:50
Conference/Events
Stifel Financial to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.